ODRE 2005 SLU 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-11 4:17 pm Sale | 2024-05-10 | 13G | Theravance Biopharma, Inc. TBPH | ODRE 2005 SLU | 0 0.000% | -4,108,318 (Position Closed) | Filing |
| 2022-04-21 11:08 am Purchase | 2022-03-18 | 13G | Theravance Biopharma, Inc. TBPH | ODRE 2005 SLU | 4,108,318 5.500% | 4,108,318 (New Position) | Filing |